The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Novo Nordisk sparked the obesity drug revolution with Ozempic and Wegovy. Now it’s racing to avoid ... Second, it could reduce competition from compounded versions of semaglutide, the active ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Ozempic (semaglutide) is a prescription ... and where to buy it in person and online. Novo Nordisk, the maker of Ozempic, prices each pen at $997.58, regardless of strength — ranging from ...

After buying a special voucher from another company, Novo Nordisk is asking ... Although semaglutide is already available as a weekly injection known as Ozempic, diabetes patients may well prefer ...

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...

(Reuters) -Ozempic ... 3 trials. Novo Nordisk launches its first GLP-1 product, liraglutide, branded as Victoza in 2009 in Europe and in 2010 in the U.S. In 2013, Novo Nordisk's semaglutide ...